Risk factors associated with relapse in Japanese patients with microscopic polyangiitis.

OBJECTIVE: We retrospectively studied the risk factors associated with relapse during remission maintenance therapy for myeloperoxidase-antineutrophil cytoplasmic autoantibody (MPO-ANCA)-positive microscopic polyangiitis (MPA). METHODS: Sixty-two patients diagnosed with MPA according to the European...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Rheumatology Vol. 39; no. 3; pp. 545 - 552
Autores principales: Wada, Takashi, Hara, Akinori, Arimura, Yoshihiro, Sada, Ken-Ei, Makino, Hirofumi
Formato: research tables/charts Journal Article
Publicado: Journal of Rheumatology Publishing Co. Ltd. Mar2012
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=108170476&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 108170476
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        0315162X
        4CM
      jtl: Journal of Rheumatology
      issn: 0315162X
      maglogo: N
    pubinfo:
      dt: Mar2012
      vid: 39
      iid: 3
      pid: 6803
      pub: Journal of Rheumatology Publishing Co. Ltd.
      place: Toronto, Ontario
    artinfo:
      ui:
        108170476
        2011494808
        10.3899/jrheum.110705
        NLM22174198
        108170476
      ppf: 545
      ppct: 7
      formats:
      tig:
        atl: Risk factors associated with relapse in Japanese patients with microscopic polyangiitis.
      aug:
        au:
          Wada, Takashi
          Hara, Akinori
          Arimura, Yoshihiro
          Sada, Ken-Ei
          Makino, Hirofumi
        affil: Division of Nephrology, Department of Laboratory Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Faculty of Medicine, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-8641, Japan. twada@m-kanazawa.jp.
      sug:
        subj:
          Recurrence Risk Factors
          Vasculitis Epidemiology
          Aged
          Clinical Assessment Tools
          Confidence Intervals
          Cox Proportional Hazards Model
          Data Analysis Software
          Data Analysis, Statistical
          Descriptive Statistics
          Female
          Funding Source
          Human
          Japan
          Kaplan-Meier Estimator
          Kruskal-Wallis Test
          Male
          Nonexperimental Studies
          Odds Ratio
          P-Value
          Regression
          Retrospective Design
          Vasculitis Drug Therapy
          Vasculitis Prognosis
          Aged: 65+ years
          Female
          Male
      ab: OBJECTIVE: We retrospectively studied the risk factors associated with relapse during remission maintenance therapy for myeloperoxidase-antineutrophil cytoplasmic autoantibody (MPO-ANCA)-positive microscopic polyangiitis (MPA). METHODS: Sixty-two patients diagnosed with MPA according to the European Medicines Agency classification algorithm during a 2-year period from January 1, 2005, to December 31, 2006, and who achieved remission after the first remission-induction therapy, were examined (registration no. UMIN000001785). RESULTS: The patient group comprised 25 men and 37 women aged 70.0 ± 8.9 years. The mean observation period was 30.2 ± 15.9 months. The rate of relapse was 24.2% (15/62), and mean interval between remission and relapse was 16.9 ± 13.5 months. During maintenance therapy following remission, the risk of relapse increased when the reduction rate of prednisolone increased above 0.8 mg/month (OR 12.6, 95% CI 2.2-97.9). Proteinuria at the start of maintenance therapy (regression coefficient 1.991 ± 0.758, p < 0.05) and the change in red blood cell counts in urine during the period from the start of maintenance therapy to the final observation (regression coefficient 0.126 ± 0.040, p < 0.01) were identified as risk factors influencing the vasculitis damage index. CONCLUSION: In Japan, relapse of MPO-ANCA-positive MPA may be associated with the reduction rate of oral prednisolone administration during maintenance therapy.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N